These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. High prevalence of Hashimoto's thyroiditis in patients with polycystic ovary syndrome: does the imbalance between estradiol and progesterone play a role? Arduc A; Aycicek Dogan B; Bilmez S; Imga Nasiroglu N; Tuna MM; Isik S; Berker D; Guler S Endocr Res; 2015; 40(4):204-10. PubMed ID: 25822940 [TBL] [Abstract][Full Text] [Related]
5. Prevalence of autoimmune thyroiditis in patients with polycystic ovary syndrome. Kachuei M; Jafari F; Kachuei A; Keshteli AH Arch Gynecol Obstet; 2012 Mar; 285(3):853-6. PubMed ID: 21866332 [TBL] [Abstract][Full Text] [Related]
6. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS). Ganie MA; Hassan S; Nisar S; Shamas N; Rashid A; Ahmed I; Douhat S; Mudassar S; Jan VM; Rashid F Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507 [TBL] [Abstract][Full Text] [Related]
7. Plasma adiponectin levels in women with polycystic ovary syndrome: impact of metformin treatment in a case-control study. Singh S; Akhtar N; Ahmad J Diabetes Metab Syndr; 2012; 6(4):207-11. PubMed ID: 23199540 [TBL] [Abstract][Full Text] [Related]
8. Studies of cardiovascular risk factors in polycystic ovary syndrome patients combined with subclinical hypothyroidism. Pei YJ; Wang AM; Zhao Y; Yan L; Li M; White RE; Han GC Gynecol Endocrinol; 2014 Aug; 30(8):553-6. PubMed ID: 24884959 [TBL] [Abstract][Full Text] [Related]
9. High prevalence of autoimmune thyroiditis in patients with polycystic ovary syndrome. Janssen OE; Mehlmauer N; Hahn S; Offner AH; Gärtner R Eur J Endocrinol; 2004 Mar; 150(3):363-9. PubMed ID: 15012623 [TBL] [Abstract][Full Text] [Related]
10. Thyroid Disorders in Young Females with Polycystic Ovary Syndrome and Correlation of Thyroid Volume with Certain Hormonal Parameters. Polat SB; Oğuz O; Sacikara M; Cuhaci FN; Evranos B; Ersoy R; Cakir B J Reprod Med; 2016; 61(1-2):27-32. PubMed ID: 26995885 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of insulin resistance and metabolic syndrome in patients with polycystic ovary syndrome. Lankarani M; Valizadeh N; Heshmat R; Peimani M; Sohrabvand F Gynecol Endocrinol; 2009 Aug; 25(8):504-7. PubMed ID: 19499403 [TBL] [Abstract][Full Text] [Related]
13. Alterations in thyroid function among the different polycystic ovary syndrome phenotypes. Morgante G; Musacchio MC; Orvieto R; Massaro MG; De Leo V Gynecol Endocrinol; 2013 Nov; 29(11):967-9. PubMed ID: 23957782 [TBL] [Abstract][Full Text] [Related]
14. Use of fasting blood to assess the prevalence of insulin resistance in women with polycystic ovary syndrome. Carmina E; Lobo RA Fertil Steril; 2004 Sep; 82(3):661-5. PubMed ID: 15374711 [TBL] [Abstract][Full Text] [Related]
15. Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment. DeUgarte CM; Bartolucci AA; Azziz R Fertil Steril; 2005 May; 83(5):1454-60. PubMed ID: 15866584 [TBL] [Abstract][Full Text] [Related]
16. Ovarian SAHA syndrome is associated with a more insulin-resistant profile and represents an independent risk factor for glucose abnormalities in women with polycystic ovary syndrome: a prospective controlled study. Dalamaga M; Papadavid E; Basios G; Vaggopoulos V; Rigopoulos D; Kassanos D; Trakakis E J Am Acad Dermatol; 2013 Dec; 69(6):922-30. PubMed ID: 24120563 [TBL] [Abstract][Full Text] [Related]
17. Reproductive hormone levels and anthropometry in postmenopausal women with polycystic ovary syndrome (PCOS): a 21-year follow-up study of women diagnosed with PCOS around 50 years ago and their age-matched controls. Schmidt J; Brännström M; Landin-Wilhelmsen K; Dahlgren E J Clin Endocrinol Metab; 2011 Jul; 96(7):2178-85. PubMed ID: 21508129 [TBL] [Abstract][Full Text] [Related]
18. The prevalence of thyroid dysfunction and hyperprolactinemia in women with PCOS. van der Ham K; Stekelenburg KJ; Louwers YV; van Dorp W; Schreurs MWJ; van der Wal R; Steegers-Theunissen RPM; Laven JSE Front Endocrinol (Lausanne); 2023; 14():1245106. PubMed ID: 37854182 [TBL] [Abstract][Full Text] [Related]
19. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome. Shi Y; Guo M; Yan J; Sun W; Zhang X; Geng L; Xu L; Chen Z Neuro Endocrinol Lett; 2007 Dec; 28(6):807-10. PubMed ID: 18063948 [TBL] [Abstract][Full Text] [Related]
20. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features. Morales AJ; Laughlin GA; Bützow T; Maheshwari H; Baumann G; Yen SS J Clin Endocrinol Metab; 1996 Aug; 81(8):2854-64. PubMed ID: 8768842 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]